Methyl morpholine oxide → 3-(5,6,7,8,9,10-Hexahydro[1,2,4]triazolo[4,3-a]azocin-3-yl)-3-(2-thienyl)cyclobutanone
反応式
[N:1]1[N:2]=[C:3]([C:12]2([C:17]3[S:18][CH:19]=[CH:20][CH:21]=3)[CH2:15][CH:14]([OH:16])[CH2:13]2)[N:4]2[CH2:11][CH2:10][CH2:9][CH2:8][CH2:7][CH2:6][C:5]=12.C[N+]1([O-])CCOCC1>C(Cl)Cl>[N:1]1[N:2]=[C:3]([C:12]2([C:17]3[S:18][CH:19]=[CH:20][CH:21]=3)[CH2:13][C:14](=[O:16])[CH2:15]2)[N:4]2[CH2:11][CH2:10][CH2:9][CH2:8][CH2:7][CH2:6][C:5]=12参加物
4
実験手順
3-(5,6,7,8,9,10-hexahydro[1,2,4]triazolo[4,3-a]azocin-3-yl)-3-(2-thienyl)cyclobutanol (2.73 g) was dissolved in methylene chloride (330 ml) and then tetra-n-propylammonium perruthenate(VII) (316 mg) and NMO (1.58 g) were added thereto, followed by stirring at room temperature for 15 hours. The reaction solution was subjected to evaporation under reduced pressure and the resulting residue was purified by column chromatography (methanol:chloroform=3:97) to obtain 2.16 g of 3-(5,6,7,8,9,10-hexahydro[1,2,4]triazolo[4,3-a]azocin-3-yl)-3-(2-thienyl)cyclobutanone (pale yellow solid).